Reports

Five ways sleep is impacting your organization

Insights for HR and benefits leaders on the impact of poor sleep on employees.

Report

Improving productivity in automotive workers with quality sleep

A case study examining Sleepio adoption and outcomes in employees of an integrated automotive services company.

Report

How to support your organization through challenging events

These days, stressful news comes in through our emails and phone alerts on a daily basis, taking a heavy toll on the mental health of many employees. It’s not surprising, then, that insomnia and anxiety are on the rise. Between 30-35% of US adults experience symptoms of insomnia, while 19.1% of US adults have an anxiety disorder. Subscribe today...

Report

Cognitive behavioral therapy (CBT) in the smartphone age

This whitepaper closely examines digital treatments — with a particular focus on solutions rooted in cognitive behavioral therapy (CBT). By weighing the pros and cons of each category, you can determine which digital treatment options best suit your organization’s unique needs.

Report

The vicious cycle of insomnia and anxiety

When insomnia and anxiety occur together, their effects can compound. A remarkable 24% to 36% of people with anxiety disorders experience insomnia, while people with insomnia are more likely to develop an anxiety disorder than those without sleep issues.

Report

How to evaluate digital treatments for insomnia and anxiety

Now more than ever, it’s crucial for companies to invest in effective workforce solutions for managing insomnia and anxiety. In this guide, we explore the key factors to consider so you can select a solution that meets the needs of your employees and supports a healthy workplace culture.

Report

Patients initiating pharmacotherapy are generally not receiving guideline-recommended care for insomnia and anxiety

While benzodiazepine and hypnotic medications are generally not indicated as first-line treatments for insomnia and anxiety, an alarming number of patients are being treated with these medications as the first and only treatment. Big Health recently engaged Milliman to conduct a study on treatment patterns for traditional Medicare beneficiaries with insomnia disorder and generalized anxiety...

Report

How a Fortune 50 workforce lowered health care costs by nearly 30% with Daylight®

The new health economic research report by a Johns Hopkins professor shows how the use of a digital therapeutic can lower overall healthcare costs.

Report

How a Fortune 50 retailer lowered health care costs by nearly 20% with Sleepio for insomnia

The new health economic research report by a Johns Hopkins professor shows use of a digital therapeutic lowers overall healthcare costs.

Report

The state of mental health equity

Insights from clinical experts focused on improving mental health disparities.

Report

1 2 3